Thursday, March 1, 2018

Inscripta Finds $55.5M For Gene Editing Tools

Boulder, Colorado- annd Pleasanton, California-based Inscripta has received $55.5M in a Series C funding, the company said this week, led by Merieux Developpement and Paladin Capital Group, and also included Venrock, Foresite, Spruce, and NanoDimension. Inscripta, which develops gene editing tools, said the new funding comes in preparation for expansion of its platform, and commercial launch. Kevin Ness is CEO of Inscripta. More information »